Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Thermo Fisher Scientific logoThermo Fisher Scientific TMO

Thermo Fisher said that in Q1 2025 its GAAP operating income margin and adjusted operating income margin decreased due primarily to unfavorable business mix, strategic investments, and the impacts of foreign exchange, largely offset by very strong productivity improvements.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Thermo Fisher said that in Q1 2025 its GAAP operating income margin and adjusted operating income margin decreased due primarily to unfavorable business mix, strategic investments, and the impacts of foreign exchange, largely offset by very strong productivity improvements.

  2. The company cited a $125 million deferred tax benefit resulting from the recognition of a tax attribute related to a domestication transaction as a factor in the decrease in its GAAP and adjusted tax rates in Q1 2025 compared to Q1 2024. It said it expects its GAAP effective tax rate in 2025 to be between 6% and 8% and its adjusted tax rate to be approximately 10.5%.

  3. The company said that during the first 3 months of 2025, issuance of debt provided $2.84 billion of cash. It used $0.84 billion for repayment of senior notes, $2.00 billion for the repurchase of 3.6 million shares of common stock, and $0.15 billion for the payment of cash dividends.

  4. Thermo Fisher said that as of March 29, 2025, short-term obligations and current maturities of long-term obligations totaled $2.82 billion, and no borrowings were outstanding under its revolving credit facility, which provides up to $5.00 billion of unsecured multi-currency revolving credit.

Key figures

Quarter ended March 29, 2025

Revenue
$10.4B
Operating income
$1.7B
Net income
$1.5B
EPS
$3.98
Operating cash flow
$723M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q1 2025 Operating Income Margin Decline and Contributing Factors

Thermo Fisher said that in Q1 2025 its GAAP operating income margin and adjusted operating income margin decreased due primarily to unfavorable business mix, strategic investments, and the impacts of foreign exchange, largely offset by very strong productivity improvements.

Source · Based on the MD&A text of the filing

Q1 Tax Rate Decline and $125 million Deferred Tax Benefit

The company cited a $125 million deferred tax benefit resulting from the recognition of a tax attribute related to a domestication transaction as a factor in the decrease in its GAAP and adjusted tax rates in Q1 2025 compared to Q1 2024. It said it expects its GAAP effective tax rate in 2025 to be between 6% and 8% and its adjusted tax rate to be approximately 10.5%.

Source · Based on the MD&A text of the filing

Q1 2025 Financing Activities: Debt Issuance and Share Repurchases

The company said that during the first 3 months of 2025, issuance of debt provided $2.84 billion of cash. It used $0.84 billion for repayment of senior notes, $2.00 billion for the repurchase of 3.6 million shares of common stock, and $0.15 billion for the payment of cash dividends.

Source · Based on the MD&A text of the filing

Short-term Obligations and Credit Facility as of March 29, 2025

Thermo Fisher said that as of March 29, 2025, short-term obligations and current maturities of long-term obligations totaled $2.82 billion, and no borrowings were outstanding under its revolving credit facility, which provides up to $5.00 billion of unsecured multi-currency revolving credit.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.